Related Experiment Video
Updated: Feb 7, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Next-generation DNA sequencing to identify novel genetic risk factors for cerebral vein thrombosis
Marcin M Gorski1, Hugoline G de Haan2, Ilaria Mancini1
1Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Insights
Cerebral vein thrombosis (CVT) risk is linked to a common variant in the ABO gene. Next-generation sequencing did not find significant associations with rare genetic variants for this rare disease.
Area of Science:
- Genetics
- Thrombosis Research
- Molecular Biology
Background:
- Cerebral vein thrombosis (CVT) is a rare but serious condition with known genetic risk factors like anticoagulant protein deficiencies and specific gene mutations.
- However, the genetic basis for CVT remains unexplained in a significant portion of patients.
- Identifying novel genetic factors is crucial for understanding CVT pathogenesis and improving risk prediction.
Purpose of the Study:
- To discover new genetic risk factors for cerebral vein thrombosis (CVT).
- Utilize targeted next-generation DNA sequencing (NGS) to analyze candidate genes involved in hemostasis and inflammation.
- Investigate both common and rare genetic variants in CVT patients compared to healthy controls.
Main Methods:
- Conducted targeted next-generation sequencing (NGS) on 171 CVT patients and 298 controls.
- Analyzed protein-coding regions of 734 candidate genes, alongside 150 ancestry markers and 28 thrombosis-associated variants.
- Employed logistic regression for single variant association and burden tests for rare variants.
Main Results:
- Identified 3723 common variants (MAF >1%) and 8839 rare variants (MAF ≤1%).
- A significant association was found between the rs8176719 insertion/deletion (indel) variant in the ABO gene and CVT (OR 2.03, P=2.07×10-6).
- Gene-based analysis of rare variants showed a tentative association with non-coding variants in the F8 locus.
Conclusions:
- Targeted NGS successfully identified a common ABO gene variant (rs8176719 indel) associated with cerebral vein thrombosis.
- No significant cumulative burden of rare variants across specific genomic loci was found to be associated with CVT.
- Further research may be needed to explore the role of rare variants and other genetic factors in CVT.
Background:
Cerebral vein thrombosis (CVT) is a rare, life-threatening disease affecting one adult per 100,000 per year. Genetic risk factors are deficiencies of the natural anticoagulant proteins antithrombin, protein C, protein S or single nucleotide polymorphisms such as factor V Leiden and prothrombin 20210A. In 20% of patients, the cause of CVT remains unknown.
Aim:
To identify novel genetic risk factors for CVT using targeted next-generation DNA sequencing (NGS).
Methods:
We investigated 171 CVT patients and 298 healthy controls. Patients were selected using the following criteria: objective diagnosis of CVT, no active cancer. We performed targeted NGS analysis of the protein-coding regions of 734 candidate genes related to hemostasis and inflammation, 150 ancestry informative markers and 28 thrombosis-associated variants.
Results:
We identified 3723 common and low frequency variants with minor allele frequency (MAF) >1% in 590 genes. Single variant association testing using logistic regression analysis identified rs8176719 insertion/deletion (indel) variant in the ABO gene associated with CVT (age and sex adjusted OR 2.03; 95% CI 1.52-2.73; P = 2.07 × 10-6; Bonferroni P = 0.008). In addition, we identified 8839 rare variants (MAF ≤ 1%) in 723 genes. Gene-based association analysis of these rare variants using a burden test revealed only a tentative association of non-coding variants located in the F8 locus with CVT.
Conclusion:
Targeted NGS identified a common indel variant rs8176719 in the ABO gene. Gene-based tests of association failed to reveal genomic loci with a cumulative burden of rare variants associated with CVT.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
DNA as a Genetic Template
DNA as a Genetic Template
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
From DNA to Protein
Animal Mitochondrial Genetics

